HARMONY BIOSCIENCES HOLDINGS (HRMY) Forecast, Price Target & Analyst Ratings

NASDAQ:HRMY • US4131971040

Current stock price

28.89 USD
-0.27 (-0.93%)
At close:
27.5 USD
-1.39 (-4.81%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HARMONY BIOSCIENCES HOLDINGS (HRMY).

Forecast Snapshot

Consensus Price Target

Price Target
$42.84
+ 48.29% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.79
Revenue Estimate
230.96M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
75.29%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$42.84
Upside
+ 48.29%
From current price of $28.89 to mean target of $42.84, Based on 17 analyst forecasts
Low
$25.25
Median
$44.88
High
$65.10

Price Target Revisions

1 Month
-7.97%
3 Months
-9.06%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for HRMY. The average price target is 42.84 USD. This implies a price increase of 48.29% is expected in the next year compared to the current price of 28.89.
The average price target has been revised downward by 9.06% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HRMY Current Analyst RatingHRMY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

HRMY Historical Analyst RatingsHRMY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
75.29%
HRMY was analyzed by 17 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about HRMY.
In the previous month the buy percentage consensus was at a similar level.
HRMY was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-25UBSMaintains Neutral -> Neutral
2026-02-25NeedhamMaintains Buy -> Buy
2026-02-25B of A SecuritiesMaintains Underperform -> Underperform
2026-02-25HC Wainwright & Co.Reiterate Buy -> Buy
2026-02-11UBSDowngrade Buy -> Neutral
2026-01-08Truist SecuritiesMaintains Buy -> Buy
2025-12-01MizuhoMaintains Outperform -> Outperform
2025-11-24NeedhamReiterate Buy -> Buy
2025-11-24HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-06MizuhoMaintains Outperform -> Outperform
2025-10-15UBSMaintains Buy -> Buy
2025-09-25MizuhoMaintains Outperform -> Outperform
2025-09-25Deutsche BankMaintains Buy -> Buy
2025-09-25HC Wainwright & Co.Maintains Buy -> Buy
2025-09-24NeedhamMaintains Buy -> Buy
2025-07-21Truist SecuritiesInitiate Buy
2025-07-10Deutsche BankMaintains Buy -> Buy
2025-05-15MizuhoMaintains Outperform -> Outperform
2025-05-07NeedhamReiterate Buy -> Buy
2025-05-06NeedhamReiterate Buy -> Buy
2025-04-28UBSMaintains Buy -> Buy
2025-04-10NeedhamReiterate Buy -> Buy
2025-04-08NeedhamReiterate Buy -> Buy
2025-04-08HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-18MizuhoMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.79
Revenue Estimate
230.96M
Revenue Q2Q
25.02%
EPS Q2Q
1.56%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
-0.87%
Revenue (3 Months)
1.82%
EPS (1 Month)
-0.81%
EPS (3 Months)
-12.90%

Next Earnings Summary

HRMY is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.79 USD and the consensus revenue estimate is 230.96M USD.
The next earnings revenue estimate has been revised upward by 1.82% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
HRMY revenue by date.HRMY revenue by date.
582.022M
32.91%		714.734M
22.80%		868.453M
21.51%		1.04B
19.75%		1.174B
12.88%		1.312B
11.75%		1.189B
-9.38%		1.147B
-3.53%		932.11M
-18.73%		565.64M
-39.32%		576.61M
1.94%
EBITDA
YoY % growth
HRMY ebitda by date.HRMY ebitda by date.
216.389M
50.69%		214.938M
-0.67%		233.804M
8.78%		331.45M
41.76%		376.99M
13.74%		344.8M
-8.54%		289.69M
-15.98%		357.81M
23.51%		453.8M
26.83%		111.69M
-75.39%		129.54M
15.98%
EBIT
YoY % growth
HRMY ebit by date.HRMY ebit by date.
192.03M
59.76%		190.826M
-0.63%		208.469M
9.25%		289.4M
38.82%		339.85M
17.43%		451.69M
32.91%		384.47M
-14.88%		383.76M
-0.18%		181.9M
-52.60%		37.689M
-79.28%		51.051M
35.45%
Operating Margin
HRMY operating margin by date.HRMY operating margin by date.
32.99%26.70%24.00%27.83%28.95%34.43%32.34%33.46%19.51%6.66%8.85%
EPS
YoY % growth
HRMY eps by date.HRMY eps by date.
2.42
-22.68%		2.51
3.72%		2.71
7.97%		3.62
33.68%		4.31
18.93%		5.06
17.52%		3.28
-35.25%		3.69
12.66%		7.64
106.84%		6.83
-10.55%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.79
1.56%		0.93
37.00%		1.00
15.29%		1.06
180.05%		0.87
10.09%		1.04
11.13%		1.05
4.75%		1.21
13.58%
Revenue
Q2Q % growth		230.96M
25.02%		251.3M
25.34%		271.08M
13.21%		288.36M
18.29%		260.05M
12.60%		289.55M
15.22%		316.06M
16.59%		333.61M
15.69%
EBITDA
Q2Q % growth		60.047M
-3.48%		74.473M
23.88%		86.253M
3.43%		93.047M
45.63%		N/AN/AN/AN/A
EBIT
Q2Q % growth		64.08M
13.93%		76.29M
58.34%		81.98M
25.19%		86.318M
123.87%		68.466M
6.84%		86.259M
13.07%		91.478M
11.59%		98.129M
13.68%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HRMY Yearly Revenue VS EstimatesHRMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
HRMY Yearly EPS VS EstimatesHRMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.17%
EPS Next 5 Year
6.39%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
14.14%
Revenue Next 5 Year
5.39%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
11.95%
EBIT Next 5 Year
7.80%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HARMONY BIOSCIENCES HOLDINGS / HRMY Forecast FAQ

What do analysts expect the price target to be for HARMONY BIOSCIENCES HOLDINGS (HRMY)?

17 analysts have analysed HRMY and the average price target is 42.84 USD. This implies a price increase of 48.29% is expected in the next year compared to the current price of 28.89.

When does HARMONY BIOSCIENCES HOLDINGS (HRMY) report earnings?

HARMONY BIOSCIENCES HOLDINGS (HRMY) will report earnings on 2026-05-04.

What are the consensus estimates for HRMY stock next earnings?

The consensus EPS estimate for the next earnings of HARMONY BIOSCIENCES HOLDINGS (HRMY) is 0.79 USD and the consensus revenue estimate is 230.96M USD.

How do analysts rate HARMONY BIOSCIENCES HOLDINGS (HRMY)?

The consensus rating for HARMONY BIOSCIENCES HOLDINGS (HRMY) is 75.2941 / 100 . This indicates that analysts generally have a positive outlook on the stock.